Rolled Pericardium Versus Cryopreserved Allograft to Treat Native or Prosthetic Aortic Infection
1 other identifier
observational
150
0 countries
N/A
Brief Summary
While surgery with anatomic reconstruction of prosthetic aortic infections and native infectious aortitis has become established over time, the ideal substitute is not clearly defined. The cryopreserved arterial allograft (AAC) recognized as resistant to infections not only presents availability problems making its use complicated, particularly in emergencies, with a certain number of long-term aneurysmal developments. The tubulized pericardium patch (PP), available in all cases, seems to give promising results in recent literature. The investigators propose a comparative study of these two substitutes in this indication. We carried out a two-center observational study including retrospectively from January 2010 to July 2023 all patients operated on for aortic prosthesis infection and native infectious aortitis with AAC reconstruction and prospectively PP patch reconstructions from July 2018 to July 2023. The diagnosis of infection was established according to the MAGIC criteria. The patients' preoperative comorbidities were collected to compare the groups. Postoperative morbidity and mortality was then compared. The medium-term evaluation consisted of comparing according to the Kaplan Meier method: postoperative mortality, permeability, reinfection rate, reoperation rate.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2010
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 2, 2010
CompletedFirst Submitted
Initial submission to the registry
December 18, 2023
CompletedFirst Posted
Study publicly available on registry
January 3, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2024
CompletedJanuary 10, 2024
January 1, 2024
1 day
December 18, 2023
January 8, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Mortality
Number of patients death during post operative stay
day 30 post operative
Reintervention
Rate of reintervention during post operative stay
30 days, 6 months, 12 months, 24 months
Post operative Major cardiovascular adverse events (MACE)
Rate of nonfatal stroke, nonfatal myocardial infarction, and cardiovascular death
day 30 post operative
Secondary Outcomes (2)
Permeability
30 days, 6 months, 12 months, 24 months
Reinfection
30 days, 6 months, 12 months, 24 months
Study Arms (2)
Cryopreserved arterial allograft
Aortic infection treated by cryopreserved arterial allograft
Rolled pericardium patch
Aortic infection treated by Pericardium patch rolled
Interventions
In situ reconstruction with explantation of the infected graft or endograft and reconstruction by allograft or pericardium
Eligibility Criteria
patients operated on for a native infection or an aortic prosthesis who had pericardium or allograft reconstruction
You may qualify if:
- All aortic intervention performed for native aortic infection reconstruction with patch or allograft
- All aortic intervention performed for infected graft reconstruction with patch or allograft
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Paul Sabatier of Toulouselead
- LUCAS BATISTELLA, MDcollaborator
- Kheira hireche, MDcollaborator
- Ludovic CANAUD, MD PhDcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
December 18, 2023
First Posted
January 3, 2024
Study Start
January 1, 2010
Primary Completion
January 2, 2010
Study Completion
June 15, 2024
Last Updated
January 10, 2024
Record last verified: 2024-01